L‐683,877: Pharmacological profile of a novel 5‐HT3 receptor antagonist
- 1 January 1992
- journal article
- Published by Wiley in Drug Development Research
- Vol. 25 (1), 17-28
- https://doi.org/10.1002/ddr.430250103
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- How we describe competitive antagonists: three questions of usageTrends in Pharmacological Sciences, 1991
- The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primatesPharmacology Biochemistry and Behavior, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Zacopride, a potent 5-HT3 antagonistJournal of Pharmacy and Pharmacology, 1988
- 5-Hydroxytryptamine Receptor SubtypesAnnual Review of Neuroscience, 1988
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESISThe Lancet, 1987
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- Depolarizing responses recorded from nodose ganglion cells of the rabbit evoked by 5-hydroxytryptamine and other substancesNeuropharmacology, 1982